Key facts
- Notable investors include Tianjin Kechuang.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Zhongke Baike
- ·The full record, as it builds
Funding rounds
No funding rounds for Zhongke Baike are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zhongke Baike
Developer of biopharmaceutical products, vaccines and diagnostic reagents focusing on pets. The company's solutions are pet biopharmaceuticals, providing clients with local medical products for the treatment of canine distemper, influenza, etc.
- Sector
- Healthcare
- HQ
- Tianjin, China
- Founded
- 2018
- Ownership
- Privately Held (backing)
Zhongke Baike doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zhongke Baike shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zhongke Baike in its N-PORT filings yet. We sweep new filings monthly.